InvestorsHub Logo
Followers 18
Posts 642
Boards Moderated 0
Alias Born 05/19/2017

Re: None

Tuesday, 10/04/2022 10:43:24 AM

Tuesday, October 04, 2022 10:43:24 AM

Post# of 403025
“In pre-clinical studies, Brilacidin shown to synergize with marketed antifungals against pathogenic species of aspergillosis, candidiasis, cryptococcosis and mucormycosis, and further exhibited potent stand-alone efficacy against Cryptococcus neoformans.

These data suggest Brilacidin has potential as a novel antifungal agent.”

BRING IT TO MARKET!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News